2013 Q4 Form 10-K Financial Statement

#000114420414017813 Filed on March 26, 2014

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2013 Q2
Revenue $1.559M $1.235M $1.366M
YoY Change 9.73% 14.67% 16.28%
Cost Of Revenue $950.0K $619.0K $582.8K
YoY Change 41.79% 35.8% 15.5%
Gross Profit $607.6K $615.7K $783.7K
YoY Change -19.0% -0.84% 16.88%
Gross Profit Margin 38.97% 49.87% 57.35%
Selling, General & Admin $490.0K $484.8K $488.1K
YoY Change -2.0% 0.31% 15.82%
% of Gross Profit 80.64% 78.74% 62.28%
Research & Development $325.0K $290.9K $271.9K
YoY Change 38.71% 29.98% 28.41%
% of Gross Profit 53.49% 47.24% 34.69%
Depreciation & Amortization $120.0K $90.00K $100.0K
YoY Change 20.0% 0.0% -9.09%
% of Gross Profit 19.75% 14.62% 12.76%
Operating Expenses $325.0K $775.7K $760.0K
YoY Change 38.71% 9.7% 20.03%
Operating Profit -$210.0K -$160.0K $23.72K
YoY Change -1780.2% 85.74% -36.57%
Interest Expense -$10.00K -$10.00K -$10.00K
YoY Change 0.0% 0.0% -50.0%
% of Operating Profit -42.15%
Other Income/Expense, Net -$30.00K $236.9K -$13.25K
YoY Change 200.0% -2965.92% 27.88%
Pretax Income -$250.0K $76.90K $10.47K
YoY Change 2400.0% -181.47% -61.27%
Income Tax -$100.0K $19.57K $4.017K
% Of Pretax Income 25.44% 38.37%
Net Earnings -$150.7K $57.34K $6.452K
YoY Change 793.74% -190.19% -57.52%
Net Earnings / Revenue -9.67% 4.64% 0.47%
Basic Earnings Per Share -$0.05 $0.02 $0.00
Diluted Earnings Per Share -$0.05 $0.02 $0.00
COMMON SHARES
Basic Shares Outstanding 3.019M shares 3.019M shares
Diluted Shares Outstanding 3.085M shares 3.077M shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.260M $5.670M $5.680M
YoY Change 7.13% 17.63% 13.37%
Cash & Equivalents $2.270M $2.935M $2.440M
Short-Term Investments $2.990M $2.740M $3.240M
Other Short-Term Assets $180.0K $180.0K $190.0K
YoY Change -5.26% 0.0% -5.0%
Inventory $1.207M $1.491M $1.573M
Prepaid Expenses $159.1K $160.3K $174.5K
Receivables $631.4K $376.1K $531.0K
Other Receivables $0.00 $27.16K $26.33K
Total Short-Term Assets $7.268M $7.744M $8.001M
YoY Change -1.3% 6.51% 10.05%
LONG-TERM ASSETS
Property, Plant & Equipment $2.525M $2.253M $2.240M
YoY Change 7.09% -7.3% -11.09%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $13.64K $14.16K $62.50K
YoY Change -78.57% -98.89% -95.04%
Total Long-Term Assets $3.693M $3.322M $3.374M
YoY Change 0.71% -10.21% -10.5%
TOTAL ASSETS
Total Short-Term Assets $7.268M $7.744M $8.001M
Total Long-Term Assets $3.693M $3.322M $3.374M
Total Assets $10.96M $11.07M $11.37M
YoY Change -0.63% 0.87% 3.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $152.2K $166.3K $171.4K
YoY Change -33.47% -2.19% 55.86%
Accrued Expenses $293.1K $212.1K $285.8K
YoY Change 14.68% 0.99% 24.25%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $190.0K $190.0K $190.0K
YoY Change 5.56% 5.56% 5.56%
Total Short-Term Liabilities $635.6K $566.5K $893.1K
YoY Change -4.53% 3.0% 71.75%
LONG-TERM LIABILITIES
Long-Term Debt $900.0K $940.0K $990.0K
YoY Change -17.43% -16.81% -16.1%
Other Long-Term Liabilities $30.00K $40.00K $40.00K
YoY Change -62.5% -55.56% -50.0%
Total Long-Term Liabilities $930.0K $980.0K $1.030M
YoY Change -20.51% -19.67% -18.25%
TOTAL LIABILITIES
Total Short-Term Liabilities $635.6K $566.5K $893.1K
Total Long-Term Liabilities $930.0K $980.0K $1.030M
Total Liabilities $1.565M $1.554M $1.929M
YoY Change -14.76% -12.18% 8.36%
SHAREHOLDERS EQUITY
Retained Earnings -$407.4K -$256.7K -$314.0K
YoY Change -22.37%
Common Stock $10.34M $10.32M $10.32M
YoY Change 0.37%
Preferred Stock
YoY Change
Treasury Stock (at cost) $514.3K $529.7K $529.7K
YoY Change -2.89%
Treasury Stock Shares 235.1K shares 242.1K shares 242.1K shares
Shareholders Equity $9.396M $9.511M $9.446M
YoY Change
Total Liabilities & Shareholders Equity $10.96M $11.07M $11.37M
YoY Change -0.63% 0.87% 3.03%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2013 Q2
OPERATING ACTIVITIES
Net Income -$150.7K $57.34K $6.452K
YoY Change 793.74% -190.19% -57.52%
Depreciation, Depletion And Amortization $120.0K $90.00K $100.0K
YoY Change 20.0% 0.0% -9.09%
Cash From Operating Activities $90.00K $70.00K $490.0K
YoY Change -43.75% -150.0% 276.92%
INVESTING ACTIVITIES
Capital Expenditures -$480.0K -$40.00K -$70.00K
YoY Change 1500.0% 300.0% -46.15%
Acquisitions
YoY Change
Other Investing Activities -$250.0K $500.0K -$250.0K
YoY Change -125.0% -32.43% -50.0%
Cash From Investing Activities -$720.0K $460.0K -$330.0K
YoY Change -174.23% -36.99% -46.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -20.00K -50.00K -50.00K
YoY Change -50.0% 25.0% 0.0%
NET CHANGE
Cash From Operating Activities 90.00K 70.00K 490.0K
Cash From Investing Activities -720.0K 460.0K -330.0K
Cash From Financing Activities -20.00K -50.00K -50.00K
Net Change In Cash -650.0K 480.0K 110.0K
YoY Change -159.63% -12.73% -120.37%
FREE CASH FLOW
Cash From Operating Activities $90.00K $70.00K $490.0K
Capital Expenditures -$480.0K -$40.00K -$70.00K
Free Cash Flow $570.0K $110.0K $560.0K
YoY Change 200.0% -184.62% 115.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
326115 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
9973146 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
10011339 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-524803 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-407408 USD
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
529655 USD
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
514341 USD
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
8000000 shares
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2673719 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2270385 USD
CY2012Q4 us-gaap Short Term Investments
ShortTermInvestments
2240000 USD
CY2013Q4 us-gaap Short Term Investments
ShortTermInvestments
2985000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
611354 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
631410 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
1649002 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
1206508 USD
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
157930 USD
CY2013Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
159117 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
31177 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
15212 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
7363182 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
7267632 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2357609 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2524765 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
1245982 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
1154681 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
63634 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13636 USD
CY2012Q4 us-gaap Assets
Assets
11030407 USD
CY2013Q4 us-gaap Assets
Assets
10960714 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
255568 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
293076 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
228711 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
152153 USD
CY2012Q4 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
181491 USD
CY2013Q4 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
190390 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
665770 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
635619 USD
CY2012Q4 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
1086568 USD
CY2013Q4 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
896224 USD
CY2012Q4 iccc Interest Rate Swap
InterestRateSwap
83386 USD
CY2013Q4 iccc Interest Rate Swap
InterestRateSwap
33002 USD
CY2012Q4 us-gaap Long Term Debt
LongTermDebt
1169954 USD
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
929226 USD
CY2012Q4 us-gaap Liabilities
Liabilities
1835724 USD
CY2013Q4 us-gaap Liabilities
Liabilities
1564845 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
326115 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-50120 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-19836 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
9194683 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
9395869 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11030407 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10960714 USD
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3261148 shares
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
235114 shares
CY2013Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
5255385 USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
8000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3261148 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
242114 shares
CY2012Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
4913719 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-403334 USD
CY2013 iccc Increase Decrease In Short Term Investments
IncreaseDecreaseInShortTermInvestments
745000 USD
CY2013 iccc Increase Decrease In Cash And Cash Equivalents And Short Term Investments
IncreaseDecreaseInCashAndCashEquivalentsAndShortTermInvestments
341666 USD
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
198441 USD
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
270355 USD
CY2012Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
986243 USD
CY2013Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
783060 USD
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
464318 USD
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
153093 USD
CY2013 iccc Increase Decrease In Raw Materials Inventories
IncreaseDecreaseInRawMaterialsInventories
71914 USD
CY2013 iccc Increase Decrease In Work In Process Inventories
IncreaseDecreaseInWorkInProcessInventories
-203183 USD
CY2013 iccc Increase Decrease In Finished Goods Inventories
IncreaseDecreaseInFinishedGoodsInventories
-311225 USD
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-442494 USD
CY2012Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
3029559 USD
CY2013Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
3182686 USD
CY2012Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
2785698 USD
CY2013Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
2940239 USD
CY2012Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
312979 USD
CY2013Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
354243 USD
CY2012Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
0 USD
CY2013Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
9600 USD
CY2012Q4 us-gaap Land
Land
50000 USD
CY2013Q4 us-gaap Land
Land
50000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6178236 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6536768 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3820627 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4012003 USD
CY2012Q4 us-gaap Security Deposit
SecurityDeposit
250 USD
CY2013Q4 us-gaap Security Deposit
SecurityDeposit
750 USD
CY2012Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
26489 USD
CY2013Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
26489 USD
CY2012Q4 us-gaap Other Assets
OtherAssets
47604 USD
CY2013Q4 us-gaap Other Assets
OtherAssets
0 USD
CY2012Q4 iccc Other Assets Gross
OtherAssetsGross
74343 USD
CY2013Q4 iccc Other Assets Gross
OtherAssetsGross
27239 USD
CY2012Q4 us-gaap Accumulated Amortization Of Noncurrent Deferred Finance Costs
AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts
10709 USD
CY2013Q4 us-gaap Accumulated Amortization Of Noncurrent Deferred Finance Costs
AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts
13603 USD
CY2013Q4 iccc Long Term Debt And Bank Debt Current Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtAndBankDebtCurrentMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
190390 USD
CY2013Q4 iccc Long Term Debt And Bank Debt Current Maturities Repayments Of Principal In Year Two
LongTermDebtAndBankDebtCurrentMaturitiesRepaymentsOfPrincipalInYearTwo
150304 USD
CY2013Q4 iccc Long Term Debt And Bank Debt Current Maturities Repayments Of Principal In Year Three
LongTermDebtAndBankDebtCurrentMaturitiesRepaymentsOfPrincipalInYearThree
57384 USD
CY2013Q4 iccc Long Term Debt And Bank Debt Current Maturities Repayments Of Principal In Year Four
LongTermDebtAndBankDebtCurrentMaturitiesRepaymentsOfPrincipalInYearFour
61056 USD
CY2013Q4 iccc Long Term Debt And Bank Debt Current Maturities Repayments Of Principal In Year Five
LongTermDebtAndBankDebtCurrentMaturitiesRepaymentsOfPrincipalInYearFive
64876 USD
CY2013Q4 iccc Long Term Debt And Bank Debt Current Maturities Repayments Of Principal After Year Five
LongTermDebtAndBankDebtCurrentMaturitiesRepaymentsOfPrincipalAfterYearFive
562604 USD
CY2013Q4 iccc Total Liabilities Debt Current Portion And Long Term Portion
TotalLiabilitiesDebtCurrentPortionAndLongTermPortion
1086614 USD
CY2010Q3 us-gaap Secured Debt
SecuredDebt
2100000 USD
CY2011Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
600000 USD
CY2011 us-gaap License Costs
LicenseCosts
0 USD
CY2012 us-gaap License Costs
LicenseCosts
0 USD
CY2013 us-gaap License Costs
LicenseCosts
250000 USD
CY2011 us-gaap Royalty Income Nonoperating
RoyaltyIncomeNonoperating
11190 USD
CY2012 us-gaap Royalty Income Nonoperating
RoyaltyIncomeNonoperating
15166 USD
CY2013 us-gaap Royalty Income Nonoperating
RoyaltyIncomeNonoperating
-3000 USD
CY2011 us-gaap Interest Income Other
InterestIncomeOther
15499 USD
CY2012 us-gaap Interest Income Other
InterestIncomeOther
17202 USD
CY2013 us-gaap Interest Income Other
InterestIncomeOther
12493 USD
CY2011 us-gaap Interest Expense Other
InterestExpenseOther
81397 USD
CY2012 us-gaap Interest Expense Other
InterestExpenseOther
75274 USD
CY2013 us-gaap Interest Expense Other
InterestExpenseOther
66689 USD
CY2011 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
-4007 USD
CY2012 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
-7067 USD
CY2013 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
34902 USD
CY2011 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-63955 USD
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-52849 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
224812 USD
CY2013Q2 iccc Exclusive Option Payment Received On Development And Marketing
ExclusiveOptionPaymentReceivedOnDevelopmentAndMarketing
250000 USD
CY2013Q3 iccc Capitalized Expenditure For Development
CapitalizedExpenditureForDevelopment
47604 USD
CY2011 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
5111143 USD
CY2012 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
5389935 USD
CY2013 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
6007176 USD
CY2011 us-gaap Cost Of Goods Sold
CostOfGoodsSold
2297339 USD
CY2012 us-gaap Cost Of Goods Sold
CostOfGoodsSold
2335676 USD
CY2013 us-gaap Cost Of Goods Sold
CostOfGoodsSold
2946570 USD
CY2011 us-gaap Gross Profit
GrossProfit
2813804 USD
CY2012 us-gaap Gross Profit
GrossProfit
3054259 USD
CY2013 us-gaap Gross Profit
GrossProfit
3060606 USD
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1720055 USD
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
917600 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1154200 USD
CY2011 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
869869 USD
CY2012 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
973217 USD
CY2013 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
986766 USD
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
856606 USD
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
918441 USD
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
939192 USD
CY2011 us-gaap Operating Expenses
OperatingExpenses
3446530 USD
CY2012 us-gaap Operating Expenses
OperatingExpenses
2809258 USD
CY2013 us-gaap Operating Expenses
OperatingExpenses
3080158 USD
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-632726 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
245001 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-19552 USD
CY2011 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
63955 USD
CY2012 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
52849 USD
CY2013 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
-224812 USD
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-696681 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
192152 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
205260 USD
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-287171 USD
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
102640 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
87865 USD
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-409510 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
89512 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
117395 USD
CY2011 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2984749 shares
CY2012 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3018296 shares
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3019407 shares
CY2011 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2984749 shares
CY2012 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3108419 shares
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3085048 shares
CY2011 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2012 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2011 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2012 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2011 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
295164 USD
CY2012 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
326513 USD
CY2013 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
395042 USD
CY2012Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
27348 USD
CY2013Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
31445 USD
CY2011 iccc Interest Rate Swap Before Taxes
InterestRateSwapBeforeTaxes
-77531 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
35985 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
31359 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
9020433 USD
CY2012 iccc Interest Rate Swap Before Taxes
InterestRateSwapBeforeTaxes
-15486 USD
CY2013 iccc Interest Rate Swap Before Taxes
InterestRateSwapBeforeTaxes
50384 USD
CY2011 iccc Income Tax Applicable To Interest Rate Swap
IncomeTaxApplicableToInterestRateSwap
27088 USD
CY2012 iccc Income Tax Applicable To Interest Rate Swap
IncomeTaxApplicableToInterestRateSwap
6178 USD
CY2013 iccc Income Tax Applicable To Interest Rate Swap
IncomeTaxApplicableToInterestRateSwap
-20100 USD
CY2011 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-50443 USD
CY2012 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-9308 USD
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
30284 USD
CY2011 iccc Total Comprehensive Income Loss
TotalComprehensiveIncomeLoss
-459953 USD
CY2012 iccc Total Comprehensive Income Loss
TotalComprehensiveIncomeLoss
80204 USD
CY2013 iccc Total Comprehensive Income Loss
TotalComprehensiveIncomeLoss
147679 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
9282401 USD
CY2011 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-50443 USD
CY2012 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-9308 USD
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
30284 USD
CY2011 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
145295 USD
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
50800 USD
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
21750 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
14518 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
7261 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
398 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
38172 USD
CY2011 us-gaap Depreciation
Depreciation
413132 USD
CY2012 us-gaap Depreciation
Depreciation
399640 USD
CY2013 us-gaap Depreciation
Depreciation
414307 USD
CY2011 us-gaap Adjustment For Amortization
AdjustmentForAmortization
5240 USD
CY2012 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2876 USD
CY2013 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2894 USD
CY2011 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-302500 USD
CY2012 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
94370 USD
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
87166 USD
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
38172 USD
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
35985 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
31359 USD
CY2011 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-10822 USD
CY2012 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-12265 USD
CY2013 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-35179 USD
CY2011 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-113717 USD
CY2012 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
227558 USD
CY2013 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
20056 USD
CY2011 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
65449 USD
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-17463 USD
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-159484 USD
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
123628 USD
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-45917 USD
CY2011 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-68152 USD
CY2012 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-48332 USD
CY2013 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
37508 USD
CY2011 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
59479 USD
CY2012 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
100047 USD
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-95503 USD
CY2011 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
8250 USD
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
21750 USD
CY2011 us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
14518 USD
CY2012 us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
7261 USD
CY2013 us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
398 USD
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
275395 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
597697 USD
CY2011 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
3227000 USD
CY2012 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
4178000 USD
CY2013 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
2489000 USD
CY2011 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
4178000 USD
CY2012 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
2240000 USD
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-8250 USD
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
CY2011 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-37315 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
344390 USD
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
243735 USD
CY2011 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
614581 USD
CY2012 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-114792 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-159297 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1098660 USD
CY2013 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
3234000 USD
CY2011 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1194735 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
1662605 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1342697 USD
CY2011 us-gaap Repayments Of Debt
RepaymentsOfDebt
145232 USD
CY2012 us-gaap Repayments Of Debt
RepaymentsOfDebt
172853 USD
CY2013 us-gaap Repayments Of Debt
RepaymentsOfDebt
181445 USD
CY2011 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
145295 USD
CY2012 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
50800 USD
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-617469 USD
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1892203 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1398985 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
781516 USD
CY2011 us-gaap Income Taxes Paid
IncomeTaxesPaid
-510 USD
CY2012 us-gaap Income Taxes Paid
IncomeTaxesPaid
-708 USD
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2011 us-gaap Interest Paid
InterestPaid
-78737 USD
CY2012 us-gaap Interest Paid
InterestPaid
-75681 USD
CY2013 us-gaap Interest Paid
InterestPaid
-67015 USD
CY2011 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
-25762 USD
CY2012 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
-4550 USD
CY2013 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
-23495 USD
CY2011 us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
-50443 USD
CY2012 us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
-9308 USD
CY2013 us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
30284 USD
CY2013 us-gaap Nature Of Operations
NatureOfOperations
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0in"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.5in"> <div><b>1.</b></div> </td> <td style="TEXT-ALIGN: justify"> <div><b>BUSINESS OPERATIONS</b></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="left">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="left">ImmuCell Corporation&#8217;s (the Company) purpose is to create scientifically-proven and practical products that result in a measurable economic impact on animal health and productivity in the dairy and beef industries. The Company was originally incorporated in Maine in 1982 and reincorporated in Delaware in 1987, in conjunction with its initial public offering of common stock. The Company is subject to certain risks associated with its stage of development including dependence on key individuals, competition from other larger companies, the successful sales of existing products and the development and acquisition of additional commercially viable products with appropriate regulatory approvals, where applicable.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2012Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1717109 USD
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Trading Symbol
TradingSymbol
ICCC
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3027034 shares
CY2013 dei Entity Registrant Name
EntityRegistrantName
IMMUCELL CORP /DE/
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0000811641
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013Q2 dei Entity Public Float
EntityPublicFloat
8308000 USD
CY2013Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1846734 USD
CY2011Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1247443 USD
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-150703 USD
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1175126 USD
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1366493 USD
CY2011Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1003451 USD
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1076749 USD
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1234701 USD
CY2011Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1304548 USD
CY2012Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1420951 USD
CY2013Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1559248 USD
CY2011Q1 us-gaap Gross Profit
GrossProfit
868235 USD
CY2012Q1 us-gaap Gross Profit
GrossProfit
1012568 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
1053567 USD
CY2011Q2 us-gaap Gross Profit
GrossProfit
694526 USD
CY2012Q2 us-gaap Gross Profit
GrossProfit
670518 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
783677 USD
CY2011Q3 us-gaap Gross Profit
GrossProfit
526034 USD
CY2012Q3 us-gaap Gross Profit
GrossProfit
620958 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
615717 USD
CY2011Q4 us-gaap Gross Profit
GrossProfit
725009 USD
CY2012Q4 us-gaap Gross Profit
GrossProfit
750215 USD
CY2013Q4 us-gaap Gross Profit
GrossProfit
607644 USD
CY2011Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
472134 USD
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
247807 USD
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
266479 USD
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0in"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.5in"> <div><strong>(n)</strong></div> </td> <td style="TEXT-ALIGN: justify"> <div><strong>Use of Estimates</strong></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="left">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="left">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual amounts could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2011 iccc Effect Of Dilutive Stock Options
EffectOfDilutiveStockOptions
0 shares
CY2012 iccc Effect Of Dilutive Stock Options
EffectOfDilutiveStockOptions
90123 shares
CY2013 iccc Effect Of Dilutive Stock Options
EffectOfDilutiveStockOptions
65641 shares
CY2011 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
236000 shares
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
39750 shares
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
63875 shares
CY2011 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
600000 USD
CY2012 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 USD
CY2013 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 USD
CY2013Q4 iccc Cash Fdic Insured Amount Limit
CashFdicInsuredAmountLimit
250000 USD
CY2012Q4 iccc Amounts In Excess Of Fdic Limits
AmountsInExcessOfFdicLimits
2173000 USD
CY2013Q4 iccc Amounts In Excess Of Fdic Limits
AmountsInExcessOfFdicLimits
1770000 USD
CY2013 us-gaap Property Plant And Equipment Gross Period Increase Decrease
PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease
358532 USD
CY2013 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease
191376 USD
CY2013 iccc Property Plant And Equipment Net Period Increase Decrease
PropertyPlantAndEquipmentNetPeriodIncreaseDecrease
167156 USD
CY2011Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1555701 USD
CY2011Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
672763 USD
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
211706 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
271858 USD
CY2011Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
304082 USD
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
223771 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
290853 USD
CY2011Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
271076 USD
CY2012Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
234316 USD
CY2013Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
325010 USD
CY2011Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-16858 USD
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
281233 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
326666 USD
CY2011Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-432860 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
37397 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
23722 USD
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-192390 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-86126 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-159967 USD
CY2011Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
9382 USD
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
12497 USD
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-209975 USD
CY2011Q1 us-gaap Net Income Loss
NetIncomeLoss
-23113 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
154761 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
204310 USD
CY2011Q2 us-gaap Net Income Loss
NetIncomeLoss
-258218 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
15187 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
6452 USD
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
-127649 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-63574 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
57336 USD
CY2011Q4 us-gaap Net Income Loss
NetIncomeLoss
-530 USD
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-16862 USD
CY2011Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2011Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2011Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2011Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2012Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2011Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2011Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2011Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2011Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2012Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2012Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
48378 USD
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
50500 USD
CY2012Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
131524 USD
CY2013Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
75310 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
75666 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
167266 USD
CY2013 iccc Employee Savings Plan Description
EmployeeSavingsPlanDescription
one month
us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.5 pure
us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.04 pure
CY2013 us-gaap Defined Benefit Plans General Information
DefinedBenefitPlansGeneralInformation
August 2012 we have matched 100% of the first 3% of each employee&#8217;s salary that is contributed to the Plan and 50% of the next 2% of each employee&#8217;s salary that is contributed to the Plan
CY2011 us-gaap Defined Benefit Plan Benefits Paid
DefinedBenefitPlanBenefitsPaid
48038 USD
CY2012 us-gaap Defined Benefit Plan Benefits Paid
DefinedBenefitPlanBenefitsPaid
51145 USD
CY2013 us-gaap Defined Benefit Plan Benefits Paid
DefinedBenefitPlanBenefitsPaid
56036 USD
CY2011 iccc Amortized Debt Issuance Expense
AmortizedDebtIssuanceExpense
5240 USD
CY2012 iccc Amortized Debt Issuance Expense
AmortizedDebtIssuanceExpense
2876 USD
CY2013 iccc Amortized Debt Issuance Expense
AmortizedDebtIssuanceExpense
2894 USD
CY2011 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
510 USD
CY2012 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
708 USD
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
301 USD
CY2011 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-250899 USD
CY2012 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
89788 USD
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
74713 USD
CY2011 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-36782 USD
CY2012 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
12144 USD
CY2013 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
12851 USD
CY2011 iccc Deferred Income Tax Expense And Benefit
DeferredIncomeTaxExpenseAndBenefit
-287681 USD
CY2012 iccc Deferred Income Tax Expense And Benefit
DeferredIncomeTaxExpenseAndBenefit
101932 USD
CY2013 iccc Deferred Income Tax Expense And Benefit
DeferredIncomeTaxExpenseAndBenefit
87564 USD
CY2011 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-236871 USD
CY2012 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
65332 USD
CY2013 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
69788 USD
CY2011 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-24276 USD
CY2012 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
8015 USD
CY2013 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
8482 USD
CY2011 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
8042 USD
CY2012 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
9766 USD
CY2013 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
10526 USD
CY2011 us-gaap Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
23796 USD
CY2012 us-gaap Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
10813 USD
CY2013 us-gaap Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
21887 USD
CY2011 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
-10270 USD
CY2012 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
30340 USD
CY2013 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
20956 USD
CY2011 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.011 pure
CY2012 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0097 pure
CY2013 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.016 pure
CY2011 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
CY2012 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
CY2013 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
CY2011 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.476 pure
CY2012 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.487 pure
CY2013 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.49 pure
CY2011 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P5Y
CY2012 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P6Y6M
CY2013 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P6Y
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
6028 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
5565 USD
CY2012Q4 iccc Deferred Tax Assets Tax Deferred Expense Product Rights
DeferredTaxAssetsTaxDeferredExpenseProductRights
201000 USD
CY2013Q4 iccc Deferred Tax Assets Tax Deferred Expense Product Rights
DeferredTaxAssetsTaxDeferredExpenseProductRights
165527 USD
CY2012Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
207529 USD
CY2013Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
235567 USD
CY2012Q4 iccc Deferred Tax Assets Operating Loss Carry Forwards Federal
DeferredTaxAssetsOperatingLossCarryForwardsFederal
592774 USD
CY2013Q4 iccc Deferred Tax Assets Operating Loss Carry Forwards Federal
DeferredTaxAssetsOperatingLossCarryForwardsFederal
525012 USD
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
238536 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
201698 USD
CY2012Q4 iccc Deferred Tax Assets Tax Deferred Expense Interest Rate Swap
DeferredTaxAssetsTaxDeferredExpenseInterestRateSwap
33263 USD
CY2013Q4 iccc Deferred Tax Assets Tax Deferred Expense Interest Rate Swap
DeferredTaxAssetsTaxDeferredExpenseInterestRateSwap
13166 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
10326 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
-15143 USD
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1277159 USD
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1169893 USD
CY2011 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
31000 shares
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
15000 shares
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
7000 shares
CY2012Q4 iccc Deferred Tax Liabilities Tax Deferred Expense Depreciation
DeferredTaxLiabilitiesTaxDeferredExpenseDepreciation
8355 USD
CY2013Q4 iccc Deferred Tax Liabilities Tax Deferred Expense Depreciation
DeferredTaxLiabilitiesTaxDeferredExpenseDepreciation
8215 USD
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
25000 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2000 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
26000 shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
49000 USD
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
25000 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
8000 USD
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.40
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.86
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.23
CY2013Q4 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.2 pure
CY2013 iccc Percentage Of Outstanding Common Stock
PercentageOfOutstandingCommonStock
0.5 pure
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
74763 USD
CY2013Q4 iccc Share Based Compensation Arrangement By Share Based Payment Award Option Termination Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionTerminationWeightedAverageExercisePrice
0.005
CY2011 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
4.91
CY2012 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
5.61
CY2013 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
4.15
CY2011 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
5.75
CY2012 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
6.25
CY2013 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
4.69
CY2011 iccc Income Tax Rate As Percenatge On Taxable Income
IncomeTaxRateAsPercenatgeOnTaxableIncome
-0.41 pure
CY2012 iccc Income Tax Rate As Percenatge On Taxable Income
IncomeTaxRateAsPercenatgeOnTaxableIncome
0.53 pure
CY2013 iccc Income Tax Rate As Percenatge On Taxable Income
IncomeTaxRateAsPercenatgeOnTaxableIncome
0.43 pure
CY2013 iccc Corporate Tax Rate
CorporateTaxRate
0.34 pure
CY2004Q4 us-gaap License Costs
LicenseCosts
965000 USD
CY2013 iccc Deferred Tax Assets Operatingloss Carryforwards State Subject To Expiration
DeferredTaxAssetsOperatinglossCarryforwardsStateSubjectToExpiration
expires in 2028, 2029, 2030 and 2031
CY2004Q4 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P15Y
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.36
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.72
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.93
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.67
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.05
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.75
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.15
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.79
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.39
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.11
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.19
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.13
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.30
CY2013 iccc Deferred Tax Asset Operatingloss Carry Forwards Federal Subject To Expiration
DeferredTaxAssetOperatinglossCarryForwardsFederalSubjectToExpiration
expires in 2029, 2030 and 2031
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.75
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
344000 USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
185000 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
223000 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
271000 USD
CY2010Q3 us-gaap Debt Issuance Costs
DebtIssuanceCosts
26489 USD
CY2011 us-gaap Advertising Expense
AdvertisingExpense
4658 USD
CY2012 us-gaap Advertising Expense
AdvertisingExpense
174314 USD
CY2013 us-gaap Advertising Expense
AdvertisingExpense
151080 USD
CY2011 iccc Share Based Compensation Decrease Increase In Income Loss Before Income Taxs Per Share
ShareBasedCompensationDecreaseIncreaseInIncomeLossBeforeIncomeTaxsPerShare
0.01
CY2012 iccc Share Based Compensation Decrease Increase In Income Loss Before Income Taxs Per Share
ShareBasedCompensationDecreaseIncreaseInIncomeLossBeforeIncomeTaxsPerShare
0.01
CY2013 iccc Share Based Compensation Decrease Increase In Income Loss Before Income Taxs Per Share
ShareBasedCompensationDecreaseIncreaseInIncomeLossBeforeIncomeTaxsPerShare
0.01
CY2011 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
0 USD
CY2012 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
1000 USD
CY2013 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
6010 USD
CY2013Q4 us-gaap Purchase Obligation
PurchaseObligation
984000 USD
CY2012Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
589257 USD
CY2013Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
609638 USD
CY2012 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
15111 USD
CY2013 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
13952 USD
CY2012Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
574146 USD
CY2013Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
595686 USD
CY2012Q4 us-gaap Other Receivables
OtherReceivables
36860 USD
CY2013Q4 us-gaap Other Receivables
OtherReceivables
35676 USD
CY2012Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
348 USD
CY2013Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
48 USD
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
21540 USD
CY2013 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
1159 USD
CY2013 iccc Increase Decrease In Accounts Receivable Gross
IncreaseDecreaseInAccountsReceivableGross
20381 USD
CY2013 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-1184 USD
CY2013 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-300 USD
CY2011 iccc Derivatives Interest Rate Swap Payments
DerivativesInterestRateSwapPayments
25094 USD
CY2012 iccc Derivatives Interest Rate Swap Payments
DerivativesInterestRateSwapPayments
23903 USD
CY2013 iccc Derivatives Interest Rate Swap Payments
DerivativesInterestRateSwapPayments
23096 USD
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
24121 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased
70.00
CY2013 iccc Planned Investments
PlannedInvestments
1258000 USD
CY2013Q4 iccc Planned Investments
PlannedInvestments
110000 USD

Files In Submission

Name View Source Status
0001144204-14-017813-index-headers.html Edgar Link pending
0001144204-14-017813-index.html Edgar Link pending
0001144204-14-017813.txt Edgar Link pending
0001144204-14-017813-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
iccc-20131231.xml Edgar Link completed
iccc-20131231.xsd Edgar Link pending
iccc-20131231_cal.xml Edgar Link unprocessable
iccc-20131231_def.xml Edgar Link unprocessable
iccc-20131231_lab.xml Edgar Link unprocessable
iccc-20131231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tchart21.jpg Edgar Link pending
v371964_10k.htm Edgar Link pending
v371964_ex23.htm Edgar Link pending
v371964_ex31.htm Edgar Link pending
v371964_ex32.htm Edgar Link pending